- Home
- MRNA vs FICO Comparison
MRNA vs FICO Comparison
Compare MRNA & FICO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | FICO |
|---|---|---|
| Founded | 2010 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.7B | 22.3B |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MRNA | FICO |
|---|---|---|
| Price | $137.95 | $1,152.56 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 13 |
| Target Price | $34.27 | ★ $1,689.92 |
| AVG Volume (30 Days) | ★ 25.3M | 371.1K |
| Earning Date | 05-01-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 21.77 | ★ 29.78 |
| EPS | N/A | ★ 28.12 |
| Revenue | ★ $19,263,000,000.00 | $1,032,475,000.00 |
| Revenue This Year | $9.36 | $27.28 |
| Revenue Next Year | $15.43 | $16.97 |
| P/E Ratio | ★ N/A | $41.15 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $870.01 |
| 52 Week High | $176.66 | $1,998.01 |
Technical Indicators
Market Signals| Indicator | MRNA | FICO |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 53.43 |
| Support Level | $41.01 | $1,124.46 |
| Resistance Level | $176.66 | $1,188.80 |
| Average True Range (ATR) | 13.95 | 41.18 |
| MACD | 5.94 | 11.81 |
| Stochastic Oscillator | 67.07 | 87.10 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.